As additional target for glioma progression was identified in the GRIA2 transcript which is edited by ADAR2 [71], where less editing at the Q/R site enhances glioblastoma invasion through activation of the Akt pathway [141]. The gene discussed is ADARB1; the disease is glioblastoma.